Gries Financial LLC Acquires 172 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Gries Financial LLC boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 10.6% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,791 shares of the healthcare conglomerate’s stock after acquiring an additional 172 shares during the quarter. Gries Financial LLC’s holdings in UnitedHealth Group were worth $906,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in UNH. Hanson & Doremus Investment Management raised its holdings in shares of UnitedHealth Group by 112.9% in the fourth quarter. Hanson & Doremus Investment Management now owns 892 shares of the healthcare conglomerate’s stock valued at $451,000 after purchasing an additional 473 shares during the last quarter. Invesco LLC boosted its position in shares of UnitedHealth Group by 7.3% in the fourth quarter. Invesco LLC now owns 1,997 shares of the healthcare conglomerate’s stock valued at $1,010,000 after acquiring an additional 136 shares during the period. Allen Capital Group LLC raised its stake in UnitedHealth Group by 5.0% in the fourth quarter. Allen Capital Group LLC now owns 10,852 shares of the healthcare conglomerate’s stock valued at $5,490,000 after purchasing an additional 515 shares in the last quarter. Iams Wealth Management LLC raised its stake in UnitedHealth Group by 2.5% in the fourth quarter. Iams Wealth Management LLC now owns 2,201 shares of the healthcare conglomerate’s stock valued at $1,113,000 after purchasing an additional 54 shares in the last quarter. Finally, Robeco Institutional Asset Management B.V. raised its stake in UnitedHealth Group by 5.3% during the fourth quarter. Robeco Institutional Asset Management B.V. now owns 710,185 shares of the healthcare conglomerate’s stock worth $359,254,000 after acquiring an additional 35,719 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

UNH stock opened at $538.29 on Thursday. The firm has a 50 day moving average of $539.43 and a 200-day moving average of $565.28. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market cap of $495.38 billion, a price-to-earnings ratio of 34.73, a PEG ratio of 1.41 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $5.83 EPS. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 29.74 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were paid a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.56%. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

Analyst Ratings Changes

Several analysts have recently weighed in on the company. KeyCorp restated an “overweight” rating and set a $650.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Deutsche Bank Aktiengesellschaft increased their price target on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. Piper Sandler lowered their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. Royal Bank of Canada lowered their target price on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 16th. Finally, Bank of America lowered their price target on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. One research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and an average price target of $629.32.

Insider Activity

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The shares were purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. This represents a 28.57 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.